New 9-Valent HPV vaccine aims to block more Cancer-Causing viruses
⭐️ VACCINE ⭐️
Ongoing
This Phase 3 trial tests a 9-valent HPV vaccine in over 9,000 healthy women aged 18-45. The vaccine targets nine HPV types linked to cervical cancer and genital warts. Researchers compare it to an existing 2-valent vaccine to see if it provides broader protection. The goal is to …
Phase: PHASE3 • Sponsor: Xiamen University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:58 UTC